ABSTRACT
Chlamydia trachomatis is one of the atypical pathogens, also a strict intracellular parasite with unique developmental cycle of prokaryotic microorganisms, resulting in infantile respiratory infections and conjunctivitis.Chlamydia trachomatis is associated with respiratory diseases such as chronic cough and bronchial asthma in children.Children infected with Chlamydia trachomatis generally have a good prognosis after treatment.At present, important progress has been made in the development of Chlamydia trachomatis vaccine.This article reviews the progress in etiology, epidemiology, clinical features, laboratory inspection, diagnosis, treatment and prevention of Chlamydia trachomatis, providing a new direction for clinical recognition and effective treatment of Chlamydia trachomatis infection.
ABSTRACT
Objective This study was provided the evidence of infection respiratory tract clinical treatment through examining 695 cases of pathogen .Methods Using indirect immunofluorescence(IFA) IgM antibody with 9 respiratory pathogen in serum of 695 patients from August 2015 to March 2016 with respiratory tract infection from espiratory ,pediatrician ,thoracic surgery clinics were detected in this paper in order to provide the basis for clinical treatment .Results The results showed that single pathogen de‐tection positive rate was 33 .9% in 695 cases ,The top three of positive rate were MP(14 .1% ) ,IFB(9 .6% ) ,RSV(4 .8% );the posi‐tive rate of two mixed infection was 7 .79% ;The postive rate of MP ,IFB have obvious difference in seasons ,but which of Coxiella burneti was no obvious seasonal difference;there was an obvious difference between the sex ratio .Conclusion MP ,IFB ,RSV infec‐tion were given priority to detection rate in our region .
ABSTRACT
The role of atypical bacteria and the effect of antibiotic treatments in acute bronchitis are still not clear. This study was conducted at 22 hospitals (17 primary care clinics and 5 university hospitals) in Korea. Outpatients (aged > or = 18 yr) who had an acute illness with a new cough and sputum (< or = 30 days) were enrolled in 2013. Multiplex real-time polymerase chain reaction (RT-PCR) was used to detect five atypical bacteria. A total of 435 patients were diagnosed as having acute bronchitis (vs. probable pneumonia, n = 75), and 1.8% (n = 8) were positive for atypical pathogens (Bordetella pertussis, n = 3; B. parapertussis, n = 0; Mycoplasma pneumoniae, n = 1; Chlamydophila pneumoniae, n = 3; Legionella pneumophila, n = 1). Among clinical symptoms and signs, only post-tussive vomiting was more frequent in patients with atypical pathogens than those without (P = 0.024). In all, 72.2% of the enrolled patients received antibiotic treatment at their first visits, and beta-lactams (29.4%) and quinolones (20.5%) were the most commonly prescribed agents. In conclusion, our study demonstrates that the incidence of atypical pathogens is low in patients with acute bronchitis, and the rate of antibiotic prescriptions is high.
Subject(s)
Female , Humans , Male , Middle Aged , Anti-Bacterial Agents/therapeutic use , Bordetella parapertussis/genetics , Bordetella pertussis/genetics , Bronchitis/drug therapy , Chlamydophila pneumoniae/genetics , Community-Acquired Infections/microbiology , Hypertension/complications , Legionella pneumophila/genetics , Mycoplasma pneumoniae/genetics , Real-Time Polymerase Chain Reaction , Republic of Korea , Sputum/microbiologyABSTRACT
The pathogens were tested in 682 cases of neonatal pneumonia,atypical pathogens were found in 167 cases (24.49％).Among the 167 cases,chlamydia trachomatis was detected in 124(74.25％),ureaplasma urealyticum in 55 (32.93％),chlamydia pneumoniae in 47 (28.14％) and mycoplasma pneumoniae in 35 (20.56％).The Chlamydia trachomatis-positive rate in mothers of 167 cases was 80.84％,ureaplasma urealyticum was 53.29％,chlamydia pneumoniae was 50.90％,Mycoplasma pneumoniae was 53.29％.The patients were treated with azithromycin and other antibiotics,151 cases were cured and 11 were effective with an overall efficacy rate of 97.01％.The liver and kidney function were tested before and after treatment; and there were no significant changes after treatment.The results show that azithromycin is safe and effective for treatment of neonatal infectious pneumonia from atypical pathogens.
ABSTRACT
OBJECTIVE To investigate the etiology of acute respiratory tract infection(ARI)in Hefei area and risk factors that may influence the distribution of common pathogens.METHODS Direct immunofluorescence assay was applied to detect the respiratory syncytial virus(RSV),adenovirus(ADV),influenza virus A(FluA),influenza virus B(FluB),parainfluenza virus PIV(1,2,3)and real time fluorescent quantitation polymerase chain reaction (FQ-PCR)was applied to measuring Mycoplasma pneumoniae(MP)and Chlamydia pneumoniae(CP)in nasopharyngeal secretions and sputum specimens.RESULTS Among 530 cases included in this study,421 cases (79.43%)showed positive viral etiology.ADV accounted for 73(13.77%),FluA-68(12.83%),FluB-56 (10.56%),RSV-48(9.05%),PIVl-47(8.86%),PIV3-42(7.92%),PIV2-33(6.22%),MP-32(6.03%)and CP-22(4.15%).The detected positive rate of pathogens isolated in winter was the highest(85.07%).CONCLUSIONS Acute upper respiratory tract infection(AURTI)is common and more than 75%pathogens in Hefei area are virus in which the most commonly virus is ADV.Meanwhile atypical pathogens of infection should not be ignored.
ABSTRACT
Mycoplasma pneumoniae,Chlamydia pneumoniae and Legionella pneumophila are recognized as common and important pathogens in community-acquired respiratory tract infections(RTIs).Macrolides,tetracyclines and fluoroquinolones are the most commonly employed drugs in the treatment of these atypical pathogen infections.Macrolide-resistant M.pneumoniae strains have been reported in Japan,China,France and the United States since 2000.Advances in atypical pathogen infections,etiological resistance and antimicrobial treatment are reviewed in this article. Abstract:Summ ary:Mycoplasma pneum oniae,Chlamydia pneum oniaeandLegionella pneum ophilaare recogn ized as common and important pathogens in commun ity-acqu ired resp iratory tract infections(RTIs).M acrolides,tetracyc lines and fluoroqu ino-lones are the most common ly emp loyed drugs in the treatm ent of these atyp ical pathogen infections.M acrolide-resistantM.pneumon iae strains have been reported in Japan,Ch ina,France and the Un ited States since 2000.Advances in atyp ical pathogen infections,etiological resistance and antim icrob ial treatm ent are reviewed in th is artic le.
ABSTRACT
Atypical pathogens are very common in community-acquired pneumonia(CAP) with the morbidity of about 22%(20%～28%).Therefore,CAP guidelines around the world usually emphasize the importance of atypical pathogens.The diagnosis tests are also listed in the guidelines,but only applied among inpatients.Japanese Respiratory Society recommended the diagnosis criteria of atypical pneumonia based on the clinical characteristics for the first time in the world.All guidelines recommended that empirical antibiotic therapy should cover those atypical pathogens when Mycoplasma pneumoniae,Chlamydia pneumonia or legionella pneumophilia infection are possibly exist.Antibiotic therapy against Mycoplasma pneumoniaen and Chlamydia pneumonia should be considered among outpatients and inpatients as well as anti-legionella pneumophilia therapy in severe patients in ICU.The recommended regimen is beta-lactam antibiotics combined with macrolides or fluoroquinolones alone.
ABSTRACT
0.05).While the diagnosis ratio of MP and LP with RT-PCR+IIF method were higher than any of other 3 methods significantly(Pa